| Cellectis S.A.. (1/3/17). "Press Release: Cellectis Submits IND Application for UCART123, an Allogeneic Gene Edited CAR T-Cell Product Candidate, in AML and BPDCN". New York, NY. |
2017-01-03 |
| Cellectis S.A.. (1/3/17). "Press Release: Cellectis to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017 at 8:00am PT". New York, NY. |
2017-01-03 |
| MorphoSys AG. (1/3/17). "Press Release: MorphoSys to Present at Upcoming Investor Conferences". Planegg. |
2017-01-03 |
| Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin. |
2017-01-04 |
| Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen. |
2017-01-04 |
| Waters Corporation. (1/4/17). "Press Release: Waters CE-Marks In Vitro Diagnostic MassTrak Vitamin D Solution". Milford, MA. |
2017-01-04 |
| Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. |
2017-01-04 |
| Merck KGaA. (1/4/17). "Press Release: Merck Acquires BioControl to Strengthen Position in Food Safety Testing". Darmstadt. |
2017-01-04 |
| Sanofi S.A.. (1/4/17). "Press Release: Sanofi Announces Soliqua 100/33 Now Available in the U.S.". Paris. |
2017-01-04 |
| Innate Pharma S.A.. (1/4/17). "Press Release: Upcoming Investor Conferences". Marseille. |
2017-01-04 |
| Pharnext S.A.. (1/4/17). "Press Release: Pharnext to Attend January Investor Conferences". Paris. |
2017-01-04 |
| Prothena Corporation plc. (1/4/17). "Press Release: Prothena to Participate in the J.P. Morgan Healthcare Conference". Dublin. |
2017-01-04 |
| Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. |
2017-01-05 |
| Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. |
2017-01-05 |
| Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. |
2017-01-05 |
| Nerre Therapeutics Ltd.. (1/5/17). "Press Release: Nerre Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round". Paris & Boston, MA. |
2017-01-05 |
| Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes. |
2017-01-05 |
| Tecan Group Ltd.. (1/5/17). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf. |
2017-01-05 |
| Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY. |
2017-01-05 |
| Iterum Therapeutics Ltd.. (1/5/17). "Press Release: Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections". Dublin & Chicago, IL. |
2017-01-05 |
| Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. |
2017-01-05 |
| Ablynx N.V.. (1/5/17). "Press Release: Ablynx to Present at the 35th J.P. Morgan Healthcare Conference". Ghent. |
2017-01-05 |
| Anokion S.A.. (1/8/17). "Press Release: Anokion Announces Exclusive Strategic Collaboration with Celgene to Develop Novel Tolerance-inducing Therapeutics for Autoimmune Diseases". Lausanne & Cambridge, MA. |
2017-01-08 |
| Kymab Group Ltd.. (1/9/17). "Press Release: Kymab Expands Infectious Disease Programmes. Kymab Receives $9m Grant from the Bill & Melinda Gates Foundation to Fund Infectious Disease Research and Development". Cambridge. |
2017-01-09 |
| F2G Ltd.. (1/9/17). "Press Release: F2G Ltd Receives European Orphan Drug Designation for its Lead Candidate F901318". Manchester. |
2017-01-09 |
| Royal Philips. (1/9/17). "Press Release: Philips and Illumina Join Forces to Offer Integrated Genomics Solutions for Oncology". Amsterdam & San Diego, CA. |
2017-01-09 |
| IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry. |
2017-01-09 |
| Eternygen GmbH. (1/9/17). "Press Release: Eternygen GmbH Closes € 8.0 (US$ 8.3) Million Series A Financing led by Epidarex Capital". Berlin. |
2017-01-09 |
| ImmuNext, Inc.. (1/9/17). "Press Release: Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases". Bridgewater, NJ & Lebanon, NH. |
2017-01-09 |
| Evotec AG. (1/9/17). "Press Release: Evotec and Eternygen to Develop Novel Metabolic Disease Therapy". Hamburg. |
2017-01-09 |
| Qiagen N.V.. (1/9/17). "Press Release: Qiagen Enhances Bioinformatics Portfolio with Acquisition of OmicSoft". Hilden & Germantown, MD. |
2017-01-09 |
| Roche. (1/9/17). "Press Release: FDA Grants Roche’s Cancer Immunotherapy Tecentriq (atezolizumab) Priority Review in Additional Type of Advanced Bladder cancer". Basel. |
2017-01-09 |
| Silence Therapeutics plc. (1/9/17). "Press Release: Acquisition of Minority Stake in Arrowhead Pharmaceuticals". London. |
2017-01-09 |
| Immatics Biotechnologies GmbH. (1/9/17). "Press Release: Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies". Thousand Oaks, CA & Tübingen. |
2017-01-09 |
| Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris. |
2017-01-09 |
| Tecan Group Ltd.. (1/10/17). "Press Release: Tecan Appoints Klaus Lun Head of the Life Sciences Business Division". Männedorf. |
2017-01-10 |
| Indivumed GmbH. (1/10/17). "Press Release: Indivumed Joins Blood Profiling Atlas in Cancer (Blood PAC)". Hamburg. |
2017-01-10 |
| AstraZeneca plc. (1/10/17). "Press Release: AstraZeneca Receives EU Approval of Fasenra for Severe Eosinophilic Asthma". |
2017-01-10 |
| Mologen AG. (1/10/17). "Press Release: Grant to Collaboration Partner for Combination Study in HIV with Lead Product Lefitolimod. Gilead Sciences, Inc. Grant for Aarhus University Hospital". Berlin. |
2017-01-10 |
| CureVac AG. (1/11/17). "Press Release: CureVac Provides Clinical Update at 35th Annual J.P. Morgan Healthcare Conference". San Francisco, CA & Tübingen. |
2017-01-11 |
| Intellia Therapeutics, Inc.. (1/11/17). "Press Release: Intellia Therapeutics Joins Genomics England’s Industry Consortium". Cambridge, MA & London. |
2017-01-11 |
| Optibrium Ltd.. (1/12/17). "Press Release: Optibrium and eMolecules Collaborate on Chemistry Data Integration in StarDrop". Cambridge & La Jolla, CA. |
2017-01-12 |
| Merck KGaA. (1/12/17). "Press Release: Merck and Palantir Launch New Healthcare Acceleration Partnership". Palo Alto, CA & Darmstadt. |
2017-01-12 |
| Lytix Biopharma AS. (1/13/17). "Press Release: Lytix Biopharma Announces the Appointment of Torbjørn Furuseth as CFO". |
2017-01-13 |
| Eppendorf AG. (1/13/17). "Press Release: William Linton Is New Member of the Supervisory Board". Hamburg. |
2017-01-13 |
| Silence Therapeutics plc. (1/13/17). "Press Release: Minority Stake in Arrowhead Pharmaceuticals". London. |
2017-01-13 |
| Evotec AG. (1/17/17). "Press Release: Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics". Toronto, ON & Hamburg. |
2017-01-17 |
| Indivumed GmbH. (1/17/17). "Press Release: Northwell Health Partners with Indivumed to Create a Cancer Research Biobank". Hamburg. |
2017-01-17 |
| Congenica Ltd.. (1/17/17). "Press Release: Congenica Expands in North America with Strategic Appointment. Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer". Cambridge. |
2017-01-17 |
| PharmaFluidics N.V.. (1/17/17). "Press Release: PharmaFluidics Raises 2.7 Million Euro to Commercialize Novel Micro-chip Device for Biomarker, Diagnostics and Drug Development Applications". Ghent. |
2017-01-17 |
| InfectoGnostics Forschungscampus Jena e. V.. (1/17/17). "Press Release: MicrobeDx Europe Founded in Jena". |
2017-01-17 |
| Agilent Technologies Inc.. (1/18/17). "Press Release: Agilent Technologies Extends Collaboration on Reproductive Genetics". Santa Clara, CA. |
2017-01-18 |
| Merck KGaA. (1/18/17). "Press Release: Merck Launches First Commercial Screening Service to Predict Multiple Sources of DNA Damage". Darmstadt. |
2017-01-18 |
| Qiagen N.V.. (1/18/17). "Press Release: Qiagen Announces Details for Completion of approximately $250 Million Synthetic Share Repurchase". Venlo. |
2017-01-18 |
| Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-01-18 |
| Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona. |
2017-01-18 |
| Gyros Protein Technologies AB. (1/19/17). "Press Release: Gyros Protein Technologies Appoints Gerrit van den Dool to Board of Directors". Uppsala. |
2017-01-19 |
| bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA. |
2017-01-19 |
| bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile. |
2017-01-19 |
| Affimed N.V.. (1/19/17). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. |
2017-01-19 |
| Qiagen N.V.. (1/19/17). "Press Release: Qiagen Announces Intention to Adjust the Conversion Ratio under Its 0.375% Senior Unsecured Convertible Notes due 2019 and Its 0.875% Senior Unsecured Convertible Notes due 2021". Venlo. |
2017-01-19 |
| Genenta Science S.r.l.. (1/19/17). "Press Release: Carlo Russo, M.D., Joins Genenta Science as Chief Medical Officer". Milan. |
2017-01-19 |
| Octimet Oncology N.V.. (1/19/17). "Press Release: Octimet Oncology NV Secures over EUR 11 Million to Develop Its Highly Selective MET kinase Inhibitors". Beerse. |
2017-01-19 |
| Abzena plc. (1/20/17). "Press Release: Abzena Signs New ThioBridge License Agreement". Cambridge. |
2017-01-20 |
| Affimed N.V.. (1/20/17). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. |
2017-01-20 |
| Merck KGaA. (1/23/17). "Press Release: Merck Announces Emerging Biotech Grant Program Winners". Darmstadt. |
2017-01-23 |
| Oasmia Pharmaceutical AB. (1/23/17). "Press Release: Oasmia Pharmaceutical Announces Strategic Move to Bolster Efforts for its Veterinary Division". Uppsala. |
2017-01-23 |
| Mologen AG. (1/23/17). "Press Release: Combination Data of TLR9 Agonist Lefitolimod with Checkpoint Inhibitors in Preclinical Tumor Models". |
2017-01-23 |
| Horizon Discovery Group plc. (1/24/17). "Press Release: Horizon Discovery Trading Update". Cambridge. |
2017-01-24 |
| ObsEva S.A.. (1/25/17). "Press Release: ObsEva SA Announces Pricing of Initial Public Offering". Geneva. |
2017-01-25 |
| Sensorion S.A.. (1/25/17). "Press Release: Sensorion to Receive €950,000 from Bpifrance and the Occitania Region". Montpellier. |
2017-01-25 |
| H. Lundbeck A/S. (1/25/17). "Press Release: Lundbeck and IBM Watson Health Form Collaboration on Technology for Developing Innovative Medicine". Valby. |
2017-01-25 |
| Lysogene S.A.. (1/25/17). "Press Release: Lysogene Launches Its IPO on Euronext’s Regulated Market in Paris". |
2017-01-25 |
| Uniqure N.V.. (1/25/17). "Press Release: Uniqure Appoints Alexander Kuta as Senior Vice President of Regulatory Affairs". Lexington, MA & Amsterdam. |
2017-01-25 |
| Affimed N.V.. (1/25/17). "Press Release: Affimed Announces Closing of Public Offering of Common Stock". Heidelberg. |
2017-01-25 |
| TxCell S.A.. (1/25/17). "Press Release: Txcell Launches a Capital Increase of around 11 Million Euros with Shareholders’ Preferential Subscription Rights [Not for release directly or indirectly in the United States of America, Canada, Australia or Japan] |
2017-01-25 |
| Actelion Ltd.. (1/26/17). "Press Release: Johnson & Johnson to Acquire Actelion for $30 Billion with Spin-out of New R&D Company". New Brunswick, NJ & Allschwil. |
2017-01-26 |
| Oxford BioTherapeutics Ltd.. (1/26/17). "Press Release: Oxford Finance Provides $10 Million Senior Debt Facility to Oxford BioTherapeutics". Alexandria, VA, San José, CA & Oxford. |
2017-01-26 |
| Caelus Health. (1/26/17). "Press Release: Caelus Health Announces First Closing of a Series A Financing Round to Advance Microbiota-based Therapeutics for Cardio-metabolic Disorders". Amsterdam. |
2017-01-26 |
| ViroVet N.V.. (1/27/17). "Press Release: Dr George Gunn, Former CEO of Novartis Animal Health, Appointed as Chairman at ViroVet". Leuven. |
2017-01-27 |
| Stallergenes Greer plc. (1/27/17). "Press Release: Stallergenes Greer Announces Positive Top-line Results of Phase 3 Study for Pediatric House Dust Mite-induced Allergic Rhinitis". |
2017-01-27 |
| Evotec AG. (1/30/17). "Press Release: Evotec to Attend Three Upcoming Investor Conferences". Hamburg. |
2017-01-30 |
| AstraZeneca plc. (1/30/17). "Press Release: US FDA Approves Symbicort (budesonide/formoterol) for the Treatment of Asthma in Paediatric Patients". |
2017-01-30 |
| Technische Universität München. (1/30/17). "Press Release: ProteomeTools – Synthetic Peptides and Spectra for Proteomics.
Milestone for the Analysis of Human Proteomes". |
2017-01-30 |
| Bruker Corporation. (1/30/17). "Press Release: Bruker and iTomography Corporation Announce License Agreement for iTomo Image Reconstruction Software". Kontich. |
2017-01-30 |
| Sanofi S.A.. (1/30/17). "Press Release: Sanofi Appoints Kathleen Tregoning to Executive Committee and Executive Vice President, External Affairs". Paris. |
2017-01-30 |
| Agilent Technologies Inc.. (1/31/17). "Press Release: Agilent Technologies Expands Dako’s CE Marked PD-L1 IHC 22C3 pharmDx Companion Diagnostics". Carpinteria, CA. |
2017-01-31 |
| Indivumed GmbH. (1/31/17). "Press Release: Indivumed Announces Agreement with Regeneron to Provide Tissue Samples for Oncology Research and Development". Hamburg. |
2017-01-31 |
| Xeltis AG. (1/31/17). "Press Release: FDA Gives Xeltis Go Ahead to Begin Trials in the USA". |
2017-01-31 |
| Axxam S.p.A.. (2/1/17). "Press Release: Axxam and Fulcrum Therapeutics Initiate a Partnership for the Provision of Drug Discovery Services for Genetic Diseases". |
2017-02-01 |
| Galapagos N.V.. (2/1/17). "Press Release: Galapagos Doses First Patient with Novel CF Corrector GLPG2222.
IND Opening Triggers $10 Million Milestone Payment from AbbVie". Mechelen. |
2017-02-01 |
| Qiagen N.V.. (2/1/17). "Press Release: Qiagen Reports Results for Fourth Quarter and Full-year 2016". Paris. |
2017-02-01 |
| Genedata AG. (2/1/17). "Press Release: New Genedata Screener APC Functionality and Integration with Nanion SyncroPatch 384PE at SLAS2017". Basel & Munich. |
2017-02-01 |
| Lonza Group AG. (2/1/17). "Press Release: Lonza Successfully Places 5.0 Million New Shares, Raising Gross Proceeds of CHF 865 Million [Not for US, CA, JP or AU]". Basel. |
2017-02-01 |
| Protagen AG. (2/2/17). "Press Release: Protagen AG Join Forces with the U.S. National Cancer Institute to Answer Pressing Questions in Immuno-oncology". |
2017-02-02 |
| AstraZeneca plc. (2/2/17). "Press Release: Full-year and Q4 2016 Results". |
2017-02-02 |
| Lysogene S.A.. (2/2/17). "Press Release: Lysogene Receives Orphan Drug Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris. |
2017-02-02 |
| InSphero AG. (2/2/17). "Press Release: InSphero to Introduce GravityTRAP 384 Microtissue Platform at SLAS2017". Schlieren. |
2017-02-02 |
| Johnson & Johnson. (2/2/17). "Press Release: Janssen Human Microbiome Institute Announces Multiple Collaborations to Accelerate the Translation of Microbiome Science into Health Solutions". Cambridge, MA. |
2017-02-02 |
| Neovacs S.A.. (2/3/17). "Press Release: Neovacs Announces Independent Data and Safety Monitoring Board Supports Continuation of Phase IIb Clinical Trial for IFNa Kinoid in Lupus". Paris. |
2017-02-03 |
![[LSUS] Life-Sciences-USA.com - The Transatlantic Life Sciences Web Portal](/images/basics/lsus-life-sciences-usa-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
